Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Centre for Clinical Vaccinology and Tropical Medicine (CCVTM) marked its 10th Anniversary on Friday the 13th of September, with the unveiling of a plaque honouring Professor Richard Moxon, the founder of the Centre.

Professor Dame Sally Davies, Chief Medical Officer, unveiled the plaque in a reception held on the lawns of the CCVTM, following an afternoon symposium where a number of the Centre’s top researchers presented their work and reviewed their achievements over the past decade.

Home to the University’s clinical vaccine development programmes, and Oxford’s base for several outstandingly successful infectious disease research programmes in Africa and Asia, speakers at the CCVTM symposium included Professors Nick Day, Director of the The Mahidol Oxford Tropical Medicine Research Unit in Thailand, Andrew Brent from the KEMRI-Wellcome Trust Research Programme in Kenya, Adrian Hill from the Jenner Institute, Andrew Pollard from the Oxford Vaccine Group, and Jeremy Farrar Director of the Oxford Clinical Research Unit in Vietnam.

At the reception following the symposium, Professor Dame Sally Davies, addressed a large gathering of researchers and high profile guests from the University, the NHS, and key funding agencies, charging her glass to Professor Richard Moxon’s vision as she unveiled the plaque in his honour.

“It’s wonderful to see the range of science that has happened here in Oxford,” Davies said, addressing Professor Moxon.

“You were ahead of your time, you made this (CCVTM) happen and you continue to make it happen; I am delighted to unveil this plaque in your honour.”

Richard Moxon said he was “deeply honoured” by the gesture but also paid tribute to the large team of people within the Collegiate University who made his vision a reality.

“I feel a truly great honour in this, but it has involved huge numbers of people,” Moxon said. “We had a wonderful working group, and to all of those who have made it happen I want to say, truly, thank you.”

Similar stories

The Oxford-Harrington Rare Disease Centre initiates first disease priority area: Friedreich’s Ataxia

The Oxford-Harrington Rare Disease Centre is redoubling efforts to develop a therapeutics programme for Friedreich’s Ataxia.

IDRM ground-breaking – work gets underway!

Work will shortly be underway on the new IMS-Tetsuya Nakamura Building, home to the new Institute of Developmental and Regenerative Medicine at Old Road Campus. The formal ground-breaking ceremony, which took place towards the end of last year, was organised by the Department of Paediatrics in collaboration with the Medical Sciences Development team.

Oxford Science Blog-Detecting Counterfeit Medicines

Bernard Naughton and Dr David Brindley from Oxford University’s Saïd Business School and Medical Sciences Division discuss the problems of identifying fake, substandard and expired medicines.

Georg Hollander and Andrew Pollard join the Fellowship of the Academy of Medical Sciences

47 world leading UK researchers, including the Department's Georg Hollander and Andrew Pollard have been elected to the prestigious Fellowship of the Academy of Medical Sciences.

Graduate Scholarship in Paediatrics

Scholarship jointly offered by St Cross College and the Department of Paediatrics